Cargando…

Analysis of multi-omics differences in left-side and right-side colon cancer

BACKGROUND: Colon cancer is one of the most common tumors in the digestive tract. Studies of left-side colon cancer (LCC) and right-side colon cancer (RCC) show that these two subtypes have different prognoses, outcomes, and clinical responses to chemotherapy. Therefore, a better understanding of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yanyi, Duanmu, Jinzhong, Liu, Yushu, Yan, Mengyun, Li, Taiyuan, Jiang, Qunguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123232/
https://www.ncbi.nlm.nih.gov/pubmed/34026368
http://dx.doi.org/10.7717/peerj.11433
_version_ 1783692841851027456
author Huang, Yanyi
Duanmu, Jinzhong
Liu, Yushu
Yan, Mengyun
Li, Taiyuan
Jiang, Qunguang
author_facet Huang, Yanyi
Duanmu, Jinzhong
Liu, Yushu
Yan, Mengyun
Li, Taiyuan
Jiang, Qunguang
author_sort Huang, Yanyi
collection PubMed
description BACKGROUND: Colon cancer is one of the most common tumors in the digestive tract. Studies of left-side colon cancer (LCC) and right-side colon cancer (RCC) show that these two subtypes have different prognoses, outcomes, and clinical responses to chemotherapy. Therefore, a better understanding of the importance of the clinical classifications of the anatomic subtypes of colon cancer is needed. METHODS: We collected colon cancer patients’ transcriptome data, clinical information, and somatic mutation data from the Cancer Genome Atlas (TCGA) database portal. The transcriptome data were taken from 390 colon cancer patients (172 LCC samples and 218 RCC samples); the somatic mutation data included 142 LCC samples and 187 RCC samples. We compared the expression and prognostic differences of LCC and RCC by conducting a multi-omics analysis of each using the clinical characteristics, immune microenvironment, transcriptomic differences, and mutation differences. The prognostic signatures was validated using the internal testing set, complete set, and external testing set (GSE39582). We also verified the independent prognostic value of the signature. RESULTS: The results of our clinical characteristic analysis showed that RCC had a significantly worse prognosis than LCC. The analysis of the immune microenvironment showed that immune infiltration was more common in RCC than LCC. The results of differential gene analysis showed that there were 360 differentially expressed genes, with 142 upregulated genes in LCC and 218 upregulated genes in RCC. The mutation frequency of RCC was generally higher than that of LCC. BRAF and KRAS gene mutations were the dominant genes mutations in RCC, and they had a strong mutual exclusion with APC, while APC gene mutation was the dominant gene mutation in LCC. This suggests that the molecular mechanisms of RCC and LCC differed. The 4-mRNA and 6-mRNA in the prognostic signatures of LCC and RCC, respectively, were highly predictive and may be used as independent prognostic factors. CONCLUSION: The clinical classification of the anatomic subtypes of colon cancer is of great significance for early diagnosis and prognostic risk assessment. Our study provides directions for individualized treatment of left and right colon cancer.
format Online
Article
Text
id pubmed-8123232
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher PeerJ Inc.
record_format MEDLINE/PubMed
spelling pubmed-81232322021-05-21 Analysis of multi-omics differences in left-side and right-side colon cancer Huang, Yanyi Duanmu, Jinzhong Liu, Yushu Yan, Mengyun Li, Taiyuan Jiang, Qunguang PeerJ Bioinformatics BACKGROUND: Colon cancer is one of the most common tumors in the digestive tract. Studies of left-side colon cancer (LCC) and right-side colon cancer (RCC) show that these two subtypes have different prognoses, outcomes, and clinical responses to chemotherapy. Therefore, a better understanding of the importance of the clinical classifications of the anatomic subtypes of colon cancer is needed. METHODS: We collected colon cancer patients’ transcriptome data, clinical information, and somatic mutation data from the Cancer Genome Atlas (TCGA) database portal. The transcriptome data were taken from 390 colon cancer patients (172 LCC samples and 218 RCC samples); the somatic mutation data included 142 LCC samples and 187 RCC samples. We compared the expression and prognostic differences of LCC and RCC by conducting a multi-omics analysis of each using the clinical characteristics, immune microenvironment, transcriptomic differences, and mutation differences. The prognostic signatures was validated using the internal testing set, complete set, and external testing set (GSE39582). We also verified the independent prognostic value of the signature. RESULTS: The results of our clinical characteristic analysis showed that RCC had a significantly worse prognosis than LCC. The analysis of the immune microenvironment showed that immune infiltration was more common in RCC than LCC. The results of differential gene analysis showed that there were 360 differentially expressed genes, with 142 upregulated genes in LCC and 218 upregulated genes in RCC. The mutation frequency of RCC was generally higher than that of LCC. BRAF and KRAS gene mutations were the dominant genes mutations in RCC, and they had a strong mutual exclusion with APC, while APC gene mutation was the dominant gene mutation in LCC. This suggests that the molecular mechanisms of RCC and LCC differed. The 4-mRNA and 6-mRNA in the prognostic signatures of LCC and RCC, respectively, were highly predictive and may be used as independent prognostic factors. CONCLUSION: The clinical classification of the anatomic subtypes of colon cancer is of great significance for early diagnosis and prognostic risk assessment. Our study provides directions for individualized treatment of left and right colon cancer. PeerJ Inc. 2021-05-12 /pmc/articles/PMC8123232/ /pubmed/34026368 http://dx.doi.org/10.7717/peerj.11433 Text en © 2021 Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Bioinformatics
Huang, Yanyi
Duanmu, Jinzhong
Liu, Yushu
Yan, Mengyun
Li, Taiyuan
Jiang, Qunguang
Analysis of multi-omics differences in left-side and right-side colon cancer
title Analysis of multi-omics differences in left-side and right-side colon cancer
title_full Analysis of multi-omics differences in left-side and right-side colon cancer
title_fullStr Analysis of multi-omics differences in left-side and right-side colon cancer
title_full_unstemmed Analysis of multi-omics differences in left-side and right-side colon cancer
title_short Analysis of multi-omics differences in left-side and right-side colon cancer
title_sort analysis of multi-omics differences in left-side and right-side colon cancer
topic Bioinformatics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123232/
https://www.ncbi.nlm.nih.gov/pubmed/34026368
http://dx.doi.org/10.7717/peerj.11433
work_keys_str_mv AT huangyanyi analysisofmultiomicsdifferencesinleftsideandrightsidecoloncancer
AT duanmujinzhong analysisofmultiomicsdifferencesinleftsideandrightsidecoloncancer
AT liuyushu analysisofmultiomicsdifferencesinleftsideandrightsidecoloncancer
AT yanmengyun analysisofmultiomicsdifferencesinleftsideandrightsidecoloncancer
AT litaiyuan analysisofmultiomicsdifferencesinleftsideandrightsidecoloncancer
AT jiangqunguang analysisofmultiomicsdifferencesinleftsideandrightsidecoloncancer